IL6 via the JAK/STAT3 pathway enhances the expression of hypoxia-inducible factor 1-alpha (HIF1α) under hypoxic and acidic conditions at tumor sites, leading to increased VEGF-A expression, which drives neovascularization and angiogenesis [143]. Here, IL6 is linked to neoplasm.